
Opinion|Videos|December 20, 2024
Important Background Information on RSV for Pharmacists
Traci M. Poole, PharmD, BCACP, BCGP, discusses the pathophysiology of respiratory syncytial virus (RSV) and its key complications, identifies high-risk populations for severe RSV infection, and explores best practices for recognizing these patients and ensuring they receive timely vaccination to prevent serious outcomes.
Advertisement
Episodes in this series

Now Playing
Video content above is prompted by the following:
- What is the pathophysiology of RSV, and what key complications may occur?
- What are the high-risk populations for getting severe RSV infection?
- What are the best practices for identifying these patients and ensuring they are vaccinated against RSV?
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Hypertension Guideline: Key Shifts for Pharmacists
2
Trastuzumab Deruxtecan Superior to Chemoimmunotherapy in HER2-Mutant Advanced NSCLC
3
Long COVID in the Pharmacy: Recognition, Referral, and the Role of Vaccination
4
The Main Street Pharmacy Access Act: A Small Bill Asking a Big Question
5







































































































